NASDAQ:OGXI
Delisted

Oncogenex Pharmaceuticals Fund Signals

etoro logo Buy OGXI
*Your capital is at risk
$0.400
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Below are some of the latest signals issued for OncoGenex Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 40 days ( 0 %
Last Price $0.400 0 %
Performance History
7 Days
$0.400 $0.400
0%
30 Days
$0.400 $0.400
0%
12 Mos
$0.600 $0.400
-33.33%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.400 - $0.400
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 15, 2018 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.1
Signal Type Signal Value Importance Data
Trend - 12 mos -26.71 % Very High Width: 97.25 %
Pred. range - 12 mos $0.178 - $0.351 High -55.53 % - -12.29 %
Short MA 12 mos Buy Very High Aug 17, 2017 - 41 days
Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Buy Low Aug 02, 2017 - 52 days
RSI Long Pivot Signal Buy Low Aug 14, 2017 - 44 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ONCOGENEX PHARMACEUTICALS INC.
OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company’s product candidates include Custirsen that is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate cancer, as well as in patients with non-small cell lung cancer; and Apatorsen, which is in two Phase I and seven randomized Phase II ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE